Agios Pharmaceuticals, Inc. (AGIO) stock
AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302% below fair value
$31.59−0.17 (-0.54%)
Close on Nov 13, 2026Market cap $1.89BP/E –Yield –
Agios Pharmaceuticals statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.93
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 6.95
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 1.71%
- 10.8%
- Shares Change (QoQ)
- 0.30%
- 0.50%
- Float
- 59M
- 49M
- Shares Held by Insiders
- 1.12%
- 11.7%
- Shares Held by Institutions
- 110.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- -5.38%
- -0.80%
- Short % of Float
- 11.1%
- 9.01%
- Short % of Shares Outstanding
- 10.9%
- 6.30%
- Days to Cover
- 5.17
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $46.00
- –
- 52-Week Low
- $22.24
- –
- 20-Day Moving Average
- $33.66
- –
- 50-Day Moving Average
- $33.09
- –
- 200-Day Moving Average
- $31.85
- –
- Average True Range (14)
- $1.85
- –
- Price Change (1 Week)
- 7.41%
- -1.15%
- Price Change (1 Month)
- -2.26%
- -4.87%
- Price Change (3 Months)
- -6.07%
- -21.0%
- Price Change (6 Months)
- 12.1%
- -20.6%
- Price Change (YTD)
- 16.1%
- -23.6%
- Price Change (1 Year)
- -27.6%
- -22.4%
- Price Change (3 Years)
- 41.7%
- -29.5%
- Price Change (5 Years)
- -24.8%
- -77.9%
- Price Change (10 Years)
- -52.8%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.33
- 0.70
- Relative Strength Index (14)
- 46.3
- 43.4
- Volatility (1 Year)
- 79.8%
- 80.1%
- Beta (5 Years)
- 1.41
- 1.07
MarginsIndustry
- EBITDA Margin
- -297.7%
- -27.7%
- FCF Margin
- -238.5%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -32.9%
- -49.9%
- Return on Assets (ROA)
- -30.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -1169.2%
- -32.9%
- Return on Capital Employed (ROCE)
- -42.5%
- -37.9%
Financial positionIndustry
- Current Ratio
- 9.69
- 3.30
- Quick Ratio
- 11.69
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 214.4%
- 6.82%
- Revenue Growth (3Y CAGR)
- 56.0%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.11
- 0.40
- Inventory Turnover
- 0.25
- 2.73
- Revenue Per Employee
- $261.30K
- $429.29K
- Profits Per Employee
- -$691.83K
- -$689.41K
- Employee Count
- 539
- 74
- WACC
- 12.1%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $907.00M
- $17.76M
- Net Cash Per Share
- $15.19
- $0.80
- Equity (Book Value)
- $979.34M
- $53.89M
- Book Value Per Share
- $16.40
- $1.50
- Tangible Book Value
- $979.34M
- $27.13M
- Working Capital
- $674.51M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$4.28M
- -$1.00M
- FCF Per Share
- -$5.63
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -19.8%
- -21.8%
- FCF Yield
- -17.8%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- 11.86
- 0.23
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AGIO | S&P 500 | Difference | AGIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.6% | -3.0% | +7.6 pts | ||
| 3 months | -5.6% | -2.8% | −2.8 pts | ||
| Year to date | +16.1% | +11.5% | +4.6 pts | ||
| 1 year | -25.7% | +13.5% | −39.2 pts | ||
| 3 years | +48.0% | +77.7% | −29.7 pts | +14.0% | +21.1% |
| 5 years | -24.8% | +72.6% | −97.4 pts | -5.5% | +11.5% |
| 10 years | -50.8% | +308.2% | −359.0 pts | -6.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M AGIO shares were sold short on Oct 30, 2026, down 5.4% from the previous report, or 11.05% of the shares available to trade. At recent volumes it would take 5.2 days to buy them back. Over the last 20 sessions, 58.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,524,140 | -5.4% | 1,261,811 | 5.2 |
| Oct 15, 2026 | 6,894,856 | -1.7% | 1,232,082 | 5.6 |
| Sep 30, 2026 | 7,016,166 | -7.2% | 1,089,910 | 6.4 |
| Sep 15, 2026 | 7,557,252 | +0.3% | 798,861 | 9.5 |
| Aug 31, 2026 | 7,535,054 | -1.2% | 893,037 | 8.4 |
| Aug 14, 2026 | 7,629,012 | +11.5% | 1,090,646 | 7.0 |
| Jul 31, 2026 | 6,840,722 | +3.2% | 1,330,207 | 5.1 |
| Jul 15, 2026 | 6,630,197 | -1.9% | 1,033,080 | 6.4 |
| Jun 30, 2026 | 6,756,481 | -2.1% | 1,331,055 | 5.1 |
| Jun 15, 2026 | 6,898,306 | -0.4% | 1,042,603 | 6.6 |
| May 29, 2026 | 6,926,807 | -7.0% | 848,565 | 8.2 |
| May 15, 2026 | 7,450,870 | +6.8% | 859,103 | 8.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?